Biocon balance sheet

As of Mar 2026

Total assets: ₹63,651cr+8.3% on Mar 2025
Shareholders' equity: ₹36,622cr+32.1% on Mar 2025
Total debt: ₹14,825cr−16.5% on Mar 2025
Cash and investments: ₹3,106cr−15.5% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	9,473	8,708	7,418	7,535
	4,613	4,102	3,985	2,588
	18,378	16,786	16,372	16,136
	8,636	6,469	6,853	5,796
	2,374	4,407	4,008	4,730
	0.0	0.0	0.0	138
	1,089	680	684	605
	639	256	412	1,228
	1,728	935	1,096	1,833
	556	258	317	301
	714	846	841	652
	46,471	42,511	40,892	39,709
	6,086	4,931	4,944	4,244
	690	447	316	1,327
	5,987	5,488	6,231	3,573
	2,417	3,227	1,234	1,324
	777	893	1,025	1,077
	337	552	715	203
	10,207	10,608	9,520	7,502
	887	0.0	715	588
	17,180	16,286	15,179	12,334
	63,651	58,797	56,071	52,043
Equity
	811	600	600	600
	33,221	21,044	19,183	17,267
	34,032	21,644	19,784	17,867
	2,590	6,069	5,491	4,622
	36,622	27,713	25,275	22,489
Liabilities
	10,746	12,405	12,932	15,291
	1,160	3,391	1,565	4,854
	11,907	15,796	14,497	20,145
	330	261	238	227
	242	358	392	382
	481	337	311	290
	12,960	16,751	15,437	21,043
	4,078	5,350	2,797	2,480
	6,772	6,549	6,272	3,983
	1,287	1,046	5,056	564
	12,137	12,944	14,126	7,028
	256	192	180	149
	416	173	277	225
	1,260	1,025	777	1,109
	14,069	14,334	15,359	8,511
	27,029	31,085	30,796	29,554
	63,651	58,797	56,071	52,043
Assets — additional as-filed lines
	—	747	0.0	0.0
Trade payables — MSME split
	135	132	—	—
	6,637	6,417	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

BIOCON₹350.70

Biocon Ltd.

· Pharma & Health

₹ CrorePeersSUNPHARMA DRREDDY SYNGENE MANKIND GLENMARK LAURUSLABS ALKEM LUPINMcap ₹56,848 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	7,535.1	7,418.1	8,708.2	9,472.8	9,472.8
+ Capital Work-in-Progress	2,587.5	3,985.2	4,101.7	4,612.7	4,612.7
+ Goodwill	16,136.2	16,372.4	16,785.7	18,377.5	18,377.5
+ Other Intangibles	5,796.4	6,853.1	6,469.4	8,635.6	8,635.6
+ Intangibles under Development	4,729.5	4,008.1	4,406.7	2,374.0	2,374.0
+ Investments (Equity Method)	137.8	0.0	0.0	0.0	0.0
+ Non-current Investments	604.5	684.1	679.7	1,089.3	1,089.3
+ Other Non-current Financial Assets	1,228.4	412.3	255.7	638.9	638.9
Non-current Financial Assets	1,832.9	1,096.4	935.4	1,728.2	1,728.2
+ Deferred Tax Assets	301.0	317.3	257.7	555.6	555.6
+ Other Non-current Assets	652.4	840.9	846.3	714.4	714.4
Total Non-current Assets	39,708.8	40,891.5	42,511.1	46,470.8	46,470.8
Current Assets
+ Inventories	4,243.7	4,943.9	4,931.1	6,085.7	6,085.7
+ Current Investments	1,326.5	315.6	447.3	689.8	689.8
+ Trade Receivables	3,573.2	6,230.6	5,487.9	5,986.8	5,986.8
+ Cash & Cash Equivalents	1,323.5	1,233.6	3,227.1	2,416.5	2,416.5
+ Other Bank Balances	1,076.6	1,025.1	893.1	777.1	777.1
+ Other Current Financial Assets	202.5	715.3	552.3	336.8	336.8
Current Financial Assets	7,502.3	9,520.2	10,607.7	10,207.0	10,207.0
+ Other Current Assets	588.0	715.1	0.0	887.1	887.1
Total Current Assets	12,334.0	15,179.2	16,286.2	17,179.8	17,179.8
Total Assets	52,042.8	56,070.7	58,797.3	63,650.6	63,650.6
Equity
+ Equity Share Capital	600.3	600.3	600.3	810.5	810.5
+ Other Equity / Reserves	17,266.6	19,183.4	21,043.7	33,221.3	33,221.3
Equity — Owners of Parent	17,866.9	19,783.7	21,644.0	34,031.8	34,031.8
+ Minority Interest	4,621.9	5,491.1	6,068.5	2,589.7	2,589.7
Total Equity	22,488.8	25,274.8	27,712.5	36,621.5	36,621.5
Liabilities
+ Borrowings — Non-current	15,290.5	12,932.4	12,405.4	10,746.3	10,746.3
+ Other Non-current Financial Liab	4,854.4	1,564.9	3,390.5	1,160.3	1,160.3
Non-current Financial Liabilities	20,144.9	14,497.3	15,795.9	11,906.6	11,906.6
+ Provisions — Non-current	226.5	237.6	260.8	330.3	330.3
+ Deferred Tax Liabilities	381.8	391.5	357.7	241.7	241.7
+ Other Non-current Liabilities	290.1	310.7	336.6	481.3	481.3
Non-current Liabilities	21,043.3	15,437.1	16,751.0	12,959.9	12,959.9
+ Borrowings — Current	2,480.2	2,797.2	5,350.1	4,078.4	4,078.4
+ Trade Payables	3,983.1	6,272.0	6,548.7	6,772.1	6,772.1
+ Other Current Financial Liab	564.4	5,056.4	1,045.5	1,286.9	1,286.9
Current Financial Liabilities	7,027.7	14,125.6	12,944.3	12,137.4	12,137.4
+ Provisions — Current	148.6	179.5	191.6	255.5	255.5
+ Current Tax Liabilities	225.0	276.9	173.1	416.0	416.0
+ Other Current Liabilities	1,109.4	776.8	1,024.8	1,260.3	1,260.3
Current Liabilities	8,510.7	15,358.8	14,333.8	14,069.2	14,069.2
Total Liabilities	29,554.0	30,795.9	31,084.8	27,029.1	27,029.1
Total Equity & Liabilities	52,042.8	56,070.7	58,797.3	63,650.6	63,650.6
Assets — additional as-filed lines
+ Current Tax Assets	0.0	0.0	747.4	—	—
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	131.5	135.1	135.1
+ Dues to Other Creditors — Current	—	—	6,417.2	6,637.0	6,637.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.